As per MRFR analysis, the India Structural Heart Devices Market Size was estimated at 35.5 (USD Million) in 2024.The India Structural Heart Devices Market Industry is expected to grow from 39.5(USD Million) in 2025 to 95 (USD Million) by 2035. The India Structural Heart Devices Market CAGR (growth rate) is expected to be around 8.305% during the forecast period (2025 - 2035).
The India Structural Heart Devices Market is experiencing significant growth due to a combination of key market drivers. One of the primary drivers is the increasing prevalence of structural heart diseases, particularly among the aging population. With the Indian government emphasizing healthcare improvements and innovation, there is a push for better management and treatment options for heart diseases.
Furthermore, advancements in technology and medical devices are leading to more effective and less invasive treatment options, thus attracting both healthcare providers and patients alike. Opportunities to be explored include the growing demand for minimally invasive procedures and devices, which becoming a preferred choice for patients and healthcare providers due to shorter recovery times and reduced hospital stays.Additionally, the rising disposable incomes among the urban population in India create a favorable environment for investing in advanced medical technologies, including structural heart devices.
Trends in recent times show a heightened focus on research and development in the Indian healthcare sector, particularly in the field of cardiovascular treatments. This is supported by various government initiatives aimed at boosting healthcare infrastructure and fostering innovation. Collaborations between Indian hospitals and international medical device manufacturers are also on the rise, paving the way for new product introductions tailored to local healthcare needs.With increasing awareness about structural heart diseases and ongoing education for both patients and healthcare professionals, there is a growing recognition of the importance of timely interventions. Overall, the India Structural Heart Devices Market stands poised for significant advancements and expansion in the coming years.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
India is experiencing a significant rise in cardiovascular diseases, which is a major driver for the India Structural Heart Devices Market Industry. According to the Indian Heart Association, approximately 30% of deaths in India are attributed to cardiovascular diseases, with an estimated 2 million deaths each year. The prevalence of risk factors such as hypertension, diabetes, and obesity has been escalating in urban areas, leading to a growing demand for structural heart devices.Organizations like the All India Institute of Medical Sciences are actively engaging in Research and Development to improve treatment options, thereby driving investment into this sector. The government's National Programme for Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases, and Stroke underscores the urgency and financial backing for innovative solutions in the cardiovascular domain, further intensifying the market growth potential.
Technological innovations in the design and functionality of structural heart devices are reshaping the India Structural Heart Devices Market Industry. The emergence of minimally invasive procedures has revolutionized patient treatment options, showcasing advancements such as transcatheter aortic valve replacement and percutaneous mitral valve repair. The Indian medical technology landscape is rapidly evolving, with organizations like Medtronic and Boston Scientific investing heavily in Research and Development.Their focus on creating advanced products with improved patient outcomes is vital to market growth. Furthermore, the Indian government has been supportive of technology transfers and collaborations, which enhance access to cutting-edge treatment and expand the market reach for structural heart devices.
India's demographic trends indicate a rapid increase in the geriatric population, with projections showing that the number of people aged 60 and above will exceed 300 million by 2050 according to the Ministry of Statistics and Programme Implementation. The elderly are more susceptible to heart conditions, creating a significant demand for structural heart devices. This demographic shift has attracted the attention of various healthcare organizations, including the Geriatric Society of India, which advocates for improved healthcare services for older adults.Their efforts to enhance awareness and resources directly stimulate the need for advanced medical devices tailored to the needs of the aging population, thereby bolstering the market.
The Indian government's focus on enhancing healthcare infrastructure and accessibility significantly influences the India Structural Heart Devices Market Industry. Initiatives such as the Ayushman Bharat scheme aim to provide comprehensive health coverage to more than 500 million individuals. This bolstered healthcare support strengthens the potential for penetration of structural heart devices in both urban and rural settings. Additionally, the government's push for 'Make in India' encourages local manufacturing of medical devices, which aligns with affordable healthcare goals.Advocacy groups such as the Association of Indian Medical Device Industry are seeking better policy constructs that allow innovation while at the same time ensuring product safety and efficacy so as to enhance the market.
The India Structural Heart Devices Market is characterized by a diverse array of devices that play a critical role in the management of structural heart diseases. This market encompasses various categories such as Heart Valve Devices, Annuloplasty Rings, Occluders, and Delivery Systems, each contributing uniquely to ensuring improved patient outcomes and operational efficiency in healthcare facilities. Heart Valve Devices are crucial as they are increasingly being adopted for minimally invasive procedures, significantly reducing recovery times and surgical risks for patients. Moreover, the growing prevalence of heart diseases in India serves as a significant growth driver for this segment, buoyed by an aging population and lifestyle changes leading to increased cardiovascular risks.
Annuloplasty Rings, which support the restoration of heart valve function, have gained traction due to their effectiveness in mitral and tricuspid valve repair, presenting exciting opportunities for surgical advancements in India. As healthcare institutions invest in modernizing their cardiac facilities, these devices are increasingly being utilized to enhance surgical outcomes and streamline procedures. Meanwhile, Occluders, designed for the treatment of conditions such as atrial septal defects, are beneficial in preventing complications associated with abnormal blood flow. They are appreciated for their minimally invasive nature, further fostering their demand amidst rising healthcare awareness among the Indian population.
Delivery Systems, essential for the accurate placement of other heart devices, have seen innovations that improve their efficacy, thereby supporting surgical precision. The ongoing advancements in technology, coupled with an increase in healthcare infrastructure, are set to propel the adoption of Structural Heart Devices in India. Market players are focusing on Research and Development to enhance the design and functionality of these devices, further driving the segmentation within the India Structural Heart Devices Market. These factors culminate in a robust environment for growth, shaping the future of heart treatment modalities in India as they aim to meet the evolving needs of patients and healthcare providers alike.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
The India Structural Heart Devices Market, particularly in the Indication segment, showcases significant growth and opportunity in areas such as Valvular Heart Disease and Cardiomyopathy. Valvular Heart Disease represents a critical concern in India, influenced by rising cardiovascular issues related to lifestyle and aging demographics, making it an important focus for innovative treatment solutions. Similarly, Cardiomyopathy, which affects the heart muscle's ability to pump blood effectively, accounts for a considerable portion of hospital admissions due to cardiovascular diseases, highlighting the need for advanced therapeutic devices.As Indian healthcare systems evolve, there is a strong demand for minimally invasive procedures that enhance patient outcomes.
This growing awareness about heart health, alongside government initiatives to improve healthcare access, propels the India Structural Heart Devices Market forward, indicating substantial potential for advancements and investments. The market, driven by advancements in technology and rising healthcare needs, is well-poised to meet the challenges posed by these significant cardiovascular conditions, underlining the relevance of investing in these critical areas for improving public health outcomes.
The Procedure segment of the India Structural Heart Devices Market consists mainly of Replacement Procedures and Repair Procedures, both of which are crucial for addressing various cardiovascular diseases prevalent in the population. Replacement Procedures, often required for severe valvular heart diseases, are gaining traction due to the aging population and rising incidences of related health issues, necessitating advanced treatments. Repair Procedures, on the other hand, play a significant role in treating conditions such as mitral regurgitation, where less invasive options are preferred, thereby offering a compelling alternative for patient management.
The growing emphasis on minimally invasive techniques further enhances the appeal of these procedures, facilitating quicker recoveries and improved patient outcomes. Moreover, advancements in technology and enhanced skills of healthcare professionals in India contribute to the increasing adoption of these procedures. The segment also faces challenges, including high costs of devices and procedural complexities, but presents ample opportunities for growth driven by increasing healthcare expenditures and better access to healthcare facilities in urban areas.As awareness grows about heart health, the Procedure segment is anticipated to witness a notable transformation, paving the way for innovation and improved patient care in the Structural Heart Devices Market.
The India Structural Heart Devices Market has been experiencing significant growth due to an increasing prevalence of cardiovascular diseases and an aging population. Competitive insights into this market reveal a landscape characterized by innovative technological advancements and a focus on minimally invasive procedures. Companies operating in this sector are focusing on enhancing their product portfolios with advanced devices that cater to the specific needs of the Indian healthcare environment.
Key players are engaging in strategic partnerships and collaborations to broaden their market reach and improve patient outcomes. With a growing emphasis on research and development, companies are also investing in developing new technologies aimed at improving the efficiency and safety of heart procedures, which is critical given the rising incidence of heart ailments in India.Cardinal Health has proved to be a formidable player in the India Structural Heart Devices Market through its commitment to quality and innovation.
The company has established a strong presence by offering a wide range of products designed specifically for structural heart diseases. Cardinal Health's strengths lie in its robust distribution network and strong customer relationships, which have facilitated the widespread adoption of its devices in hospitals and clinics across India. Furthermore, the company's continuous focus on training healthcare professionals ensures effective usage of its products, thereby enhancing patient care.
The combination of advanced technology, strategic partnerships, and a deep understanding of the Indian market has allowed Cardinal Health to stand out amid increasing competition.Merit Medical Systems holds a notable position in the India Structural Heart Devices Market, providing various innovative solutions tailored for cardiovascular treatments. The company specializes in a diverse range of products, including those used in transcatheter procedures, guiding catheters, and other vital instruments that play a critical role in structural heart interventions.
Merit Medical Systems benefits from its strategic focus on innovation and the continuous expansion of its product portfolio to meet the evolving needs of the Indian market. The company has also pursued key partnerships and potential mergers to enhance its capabilities and market standing in India. Its dedication to quality and patient safety, coupled with strong relationships with healthcare providers, positions Merit Medical Systems favorably within this competitive landscape.
The India Structural Heart Devices Market has seen significant developments recently, with key players like Abbott, Edwards Lifesciences, and Boston Scientific actively expanding their product offerings and market presence. In April 2023, Abbott launched its innovative heart valve device in India aimed at treating structural heart conditions enhancing patient outcomes. Concurrently, in June 2023, Edwards Lifesciences announced the acquisition of a local competitor, aligning with the growing demand for minimally invasive procedures in the country. Medtronic and Terumo Corporation have also ramped up investments in Research and Development to innovate more effective devices for cardiac care.
The Indian government’s push for advanced healthcare technologies, evidenced by initiatives such as the National Health Mission, is propelling growth in this sector. Furthermore, in the last two years, the rising prevalence of cardiovascular diseases has underscored the urgent need for advanced treatment options, fueling market expansion for companies like Stryker and LivaNova. With an increasing focus on cardiovascular health, coupled with the rapid adoption of healthcare technologies in India, the structural heart devices market is positioned for robust growth, benefiting both healthcare providers and patients alike.
Report Scope:
| Report Attribute/Metric Source: | Details |
| MARKET SIZE 2018 | 35.5(USD Million) |
| MARKET SIZE 2024 | 39.5(USD Million) |
| MARKET SIZE 2035 | 95.0(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 8.305% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| MARKET FORECAST PERIOD | 2025 - 2035 |
| HISTORICAL DATA | 2019 - 2024 |
| MARKET FORECAST UNITS | USD Million |
| KEY COMPANIES PROFILED | Cardinal Health, Merit Medical Systems, Terumo Corporation, Edwards Lifesciences, Abbott, Alcon, Stryker, Janssen Pharmaceuticals, Corindus Vascular Robotics, Boston Scientific, LivaNova, AtriCure, Medtronic, Glenveigh Medical, Pleura Technologies |
| SEGMENTS COVERED | Type, Indication, Procedure |
| KEY MARKET OPPORTUNITIES | Growing aging population demand, Increasing prevalence of heart diseases, Advancements in minimally invasive procedures, Expanding healthcare infrastructure, Rising awareness and education programs |
| KEY MARKET DYNAMICS | rising prevalence of heart diseases, increasing aging population, advanced technological innovations, favorable regulatory environment, growing awareness and lifestyle changes |
| COUNTRIES COVERED | India |
Frequently Asked Questions (FAQ) :
The India Structural Heart Devices Market is expected to be valued at 39.5 million USD in 2024.
By 2035, the market is projected to reach a value of 95.0 million USD.
The market is expected to grow at a CAGR of 8.305 percent during the forecast period from 2025 to 2035.
Heart Valve Devices are projected to be the largest segment in 2024, valued at 15.0 million USD.
The Annuloplasty Rings segment is expected to be valued at 24.0 million USD by 2035.
Major players include Cardinal Health, Edwards Lifesciences, Abbott, and Boston Scientific among others.
The Occluders segment is forecasted to reach a value of 19.0 million USD by 2035.
Growth is driven by increasing prevalence of heart diseases and advancements in medical technologies.
The Delivery Systems segment is expected to be valued at 6.5 million USD in 2024.
The market may experience fluctuations due to global supply chain challenges and regulatory changes.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Analyst Explore the profile of garvit vyas, one of our esteemed authors at market research future, and access their expert research contributions in the field of market research and industry analysis
Get in Touch
© 2025 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
